FDA approves Humira’s biosimilar Hulio for rheumatoid arthritis
Mylan and Fujifilm Kyowa Kirin Biologics have been working under the partnership since 2018 for the commercialisation of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Jul 20
Mylan and Fujifilm Kyowa Kirin Biologics have been working under the partnership since 2018 for the commercialisation of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
29 Jun 20
Piramal Pharma includes Piramal Pharma Solutions, an end-to-end contract development and manufacturing (CDMO) business, Piramal Critical Care, a…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
24 Jun 20
Pionyr Immunotherapeutics is a privately held pharmaceutical company engaged in developing a research approach, dubbed Myeloid Tuning
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
22 May 20
Remdesivir has been recently granted the US Food and Drug Administration (FDA) Emergency Use Authorisation (EUA) for the…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
05 May 20
Stemline’s ELZONRIS is an FDA-approved and commercially available targeted therapy to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN)
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
30 Apr 20
Supernus will acquire APOKYN, MYOBLOC, and XADAGO, along with Apomorphine Infusion Pump, which is currently under late-stage development
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
In October 2018, then-home secretary Sajid Javid passed a law making the use of medicinal cannabis to treat…
03 Mar 20
The portfolio of non-core assets includes over-the-counter (OTC) and prescription pharmaceutical products and is part of Takeda’s growth…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
21 Feb 20
The deal expands Lilly’s portfolio of medicines with the addition of lebrikizumabfor, for atopic dermatitis and QBREXZA for…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
The new type 2 diabetes treatment is a daily pill containing empagliflozin, linagliptin and extended release metformin hydrochloride